Why Should You Attend:

This webinar is designed to provide a comprehensive overview of impurities which must be controlled in pharmaceutical products, detailed review of the guidance documents related to each of the categories of impurities and strategies to address each, including reporting of test results. Topics for discussion include general impurities (not structurally related to the drug substance), such as residual solvents, elemental impurities, and microbial issues, and drug-related impurities, including process impurities, normal degradation products and potential genotoxic impurities.

Interaction and questions from the participants are actively encouraged throughout, and there will be ample time for questions at the end of the presentation.